- ONRamp RBC Innovation Hub, 100 College St, Toronto, Ontario M5G 1X5
- U of T Community Event
- March 18, 2019 from 5:00pm to 7:00pm
Tramadol Uk Online With over 500 new start up companies in the last 10 years, U of T is among the global top 5 university-managed incubators and #1 in Canada for research-based startups! Our annual celebration of all things entrepreneurship at U of T – the U of T Entrepreneurship Week – is coming March 18-22, 2019. This week is jam packed with educational events, networking events, pitch competitions and so much more.
here To kick off this week H2i has organized a seminar on Stress Management for Entrepreneurs!
go to link On Monday March 18th from 5-7pm attendees will learn all about the impact of stress as well as acquire techniques and tips to better manage stress. You will also hear personal stories from our panel of entrepreneurs and CEOs on how they manage stress along the way.
Order Tramadol Mexico Keynote Speaker:
http://caligemhealth.com.au/health-services/family-medicine/ Liam O’Leary, Programming Coordinator, Office of Graduate Professional Development, University of Toronto
enter site Liam O’Leary is a lover of all things involving black coffee and bicycles. He is a certified coach and the lead for graduate professional development at the University of Toronto. He takes a solution-focused approach to supporting students in their personal, academic, and professional growth. You can find him at Grad Room on the St. George campus.
Jual Obat Tramadol Online Panelists
Cheap Tramadol Tom Reeves, President & CEO, Interface Biologics
http://therapeuticaxis.com.au/counseling-psychotherapy/grief-loss/ Tom Reeves is President and Chief Executive Officer of Interface Biologics (IBI) – an early commercial stage privately held company that develops innovative materials for Medtech and Pharmaceutical applications. IBI surface modification additives are used in FDA-approved medical devices and are clinically proven to reduce infection and thrombus-related complications. IBI’s sustained local drug delivery technology is applicable across a range of drug classes and medical specialties with an initial focus on ophthalmology. Tom is also on the Board of Directors for both Medcan and Soricimed Biopharma and was a finalist for the 2014 Ernst & Young Entrepreneur of the Year in Health Sciences. Prior to IBI, Tom was President and Chief Operating Office of Occulogix, Inc., a publicly traded medical device company focused on treatments for age-related eye diseases. He was instrumental in the company’s 2004 IPO, which raised $100M on a $500M valuation. Prior to OccuLogix, Tom was President and CEO of Borderfree, Ltd., a venture-backed international e-commerce service provider which was sold to Canada Post. Tom also spent 14 years in the computer products industry managing wholesale distribution companies in Canada, Europe and the UK. He began his career at the Boston Consulting Group in San Francisco and has degrees in economics and international relations from Harvard University and the Australian National University.
Tramadol Europe Buy Christine Allen, PhD
http://blueturtlebeachhouse.com/menikmati-surfing-lokal-sekelas-hawai-di-pulau-sipora/ Christine Allen is a Professor and the GSK Chair in Pharmaceutics and Drug Delivery in the Leslie Dan Faculty of Pharmacy at the University of Toronto. She is also currently serving as interim Dean and previously served as the Associate Dean Academic and Associate Dean Graduate Education. Dr. Allen’s research is focused on the design and development of new materials and technologies for the delivery of drugs and contrast agents. She has received career awards from CIHR-Rx&D, CSPS and AFPC. She is co-founder and President of Nanovista Inc., a start-up housed in JLabs, which is focused on the development of multimodal contrast agents to improve the performance of image-guided high precision cancer therapy. Christine is the President Elect of CSPS and a member of the Governing Council of NSERC.
follow site Wendy Naimark, Vice President R&D, Interface Biologics
Tramadol Sales Online Dr. Wendy Naimark is currently the vice president of R&D at Interface Biologics. She spent 11 years at Boston Scientific in various management and R&D roles in the areas of Interventional Cardiology, Peripheral Interventions, Imaging, Endosurgery, Urology/Women’s health and Neurovascular. Wendy most recently served for five years as Senior Director, Clinical and Preclinical Sciences at 480 Medical, an early stage drug delivery device company in the cardiovascular space. Wendy received her MSc and PhD from the University of Toronto in Biomaterials. She is the inventor of 27 US patents and author of 12 peer-reviewed publications.
click This event is open to all students & entrepreneurs in the UofT Community
5:00 – Introductions
5:10 – Liam O’Leary
5:30 – 6:00 – Panelists each will give a 10 minute talk
6:00 – 6:45 – Panel discussion / Q & A
6:45 – 7:00 – Networking / wrap up